SYMPHONY MEDICAL, LLC v. FFD GA HOLDINGS, LLC

CourtCourt of Appeals of Georgia
DecidedOctober 12, 2023
DocketA23A0862
StatusPublished

This text of SYMPHONY MEDICAL, LLC v. FFD GA HOLDINGS, LLC (SYMPHONY MEDICAL, LLC v. FFD GA HOLDINGS, LLC) is published on Counsel Stack Legal Research, covering Court of Appeals of Georgia primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
SYMPHONY MEDICAL, LLC v. FFD GA HOLDINGS, LLC, (Ga. Ct. App. 2023).

Opinion

FOURTH DIVISION DILLARD, P. J., RICKMAN and PIPKIN, JJ.

NOTICE: Motions for reconsideration must be physically received in our clerk’s office within ten days of the date of decision to be deemed timely filed. https://www.gaappeals.us/rules-1-8/

October 12, 2023

In the Court of Appeals of Georgia A23A0862. SYMPHONY MEDICAL, LLC v. FFD GA HOLDINGS, LLC et al. A23A0877. GA BIOSCIENCE RESEARCH, INC. v. GEORGIA ACCESS TO MEDICAL CANNABIS COMMISSION et al. A23A0920. PURE PEACH ORGANIC, INC. v. FFD HOLDINGS LLC, et al. A23A1017, A23A1018. CURALEAF GEORGIA HOLDINGS, LLC v. GEORGIA ACCESS TO MEDICAL CANNABIS COMMISSION et al. A23A1091, A23A1092. ACC, LLC v. GEORGIA ACCESS TO MEDICAL CANNABIS COMMISSION et al.

PIPKIN, Judge.

Each of the Appellants in these seven discretionary appeals was an

unsuccessful applicant for a license to produce cannabis and manufacture “low THC

oil” in the State of Georgia, and these cases all involve the same question, namely,

whether the Georgia Administrative Procedure Act (“APA” or “Act”), see OCGA §

50-13-1, et seq., provides a mechanism for judicial review of the licensing decision. We consolidated these cases for the purposes of this appeal, and, as more fully

explained below, we conclude that the APA does not apply under these

circumstances; we also conclude, however, that some of these appeals are moot. Thus,

we affirm in part and dismiss as moot in part.

1. To understand the circumstances of this appeal, a bit of background is

necessary. In 2015, the Georgia General Assembly passed “Haleigh’s Hope Act,”

which “permitted [certain] medical patients to possess and use low

tetrahydrocannabinol (THC) oil of twenty fluid ounces or less.” Allyson M. Clawson,

Kady D. Litwer, Crimes and Offenses, 36 GA. ST. U. L. REV. 39, 41 (2019). See also

Ga. L. 2015, p.__, § 1-1. In reality, though, these “patients had practically no legal

way to gain access to the THC oil because it [remained] illegal to ‘grow, buy, sell or

transport the drug’ in Georgia.” (Citation and punctuation omitted.) Clawson, at 42.

The General Assembly addressed this incongruity in 2019 with the passage of

“Georgia’s Hope Act,” which, among other things, provides “for the production,

manufacturing, and dispensing of low THC oil in this state,” as well as “for the

creation of the Georgia Access to Medical Cannabis Commission.” See Ga. Law

2 2019, p.___, §§ 1, 2. The Hope Act as codified, see OCGA § 16-12-200, et seq.,1

empowers the newly created Georgia Access to Medical Cannabis Commission

(“GMCC”) to issue Class 1 and Class 2 production licenses – six licenses in total2 –

which authorizes the licensee to “[g]row cannabis . . . in indoor facilities for the use

of producing low THC oil” and to “manufacture low THC oil,” OCGA §§ 16-12-211

(a), 212 (a) (2019). These production licenses are issued by the GMCC “pursuant to

contracts awarded through competitive sealed bids or competitive sealed proposals.”

OCGA § 16-12-221 (a) (2019). This competitive process for the production licenses

is where this matter begins.

In November 2020, the GMCC began the application process for both classes

of production licenses with the release of the Competitive Application Request for

Proposals. This “competitive sealed proposal process” was designed to identify and

contract with sources to provide the needed goods or services for the production of

low THC oil. The GMCC published application instructions that, among other things,

1 The General Assembly has since revised and amended portions of the Hope Act effective July 1, 2021, see Ga. L. 2021, p. ___, §§ 2-24; however, because the relevant events occurred prior to that date, we rely on the statutes as enacted in 2019. 2 The GMCC is authorized to issue two Class 1 licenses and four Class 2 licenses. OCGA §§ 16-12-211 (a), 212 (a). The differences between the two license classes is immaterial to these appeals, but the two classes generally differ with respect to certain financial requirements and the scope of production.

3 highlighted the metrics by which the applications would be evaluated, explained how

the competitive proposals would be rated and scored and, further, advised applicants

that production licenses would be awarded to the “most highly scored applicants at

the conclusion of the evaluation process.” The results of the evaluation would,

according to the instructions, be announced by way of a “public posting of a Notice

of Intent to Award,” which “is not notice of an actual contract award[, but] instead,

the NOIA is a notice of GMCC’s expected contract award(s) pending resolution of

the protest process.”

Regarding the post-award protest, the application instructions reflect, in

relevant part, that any such protest had to be brought in writing; that the protesting

party was entitled to a hearing at which they could present oral argument; that the

parties3 had “the right to submit briefs, documents, and witness testimony in the form

of affidavits” in advance of the hearing; that the parties had the right to have counsel

present at their own expense; that the protesting party had the burden of showing

“competitive prejudice,” that is, “but for the [GMCC’s] actions, the protesting party

would have had a substantial chance of receiving an award”; and, finally, that the

decision of the hearing officer was the final decision on the protest.

3 The prevailing applicants were also entitled to participate in the protest proceedings.

4 Appellants GA Bioscience Research, Inc., Curaleaf GA Holdings, LLC, and

ACC, LLC, each applied for both a Class 1 and Class 2 production license;

Appellants Symphony Medical, LLC, and Pure Peach Organic, Inc., applied for only

a Class 2 production license. Each Appellant, though, was listed on the relevant

NOIA as an “apparent unsuccessful applicant[]” because their respective applications

were “not [the] highest scoring.” While the record before this Court is limited,4 it is

clear that each Appellant lodged a post-award protest and that, following legal

argument before a hearing officer, their claims for relief were denied, leaving the

GMCC free to issue the production licenses to the prevailing applicants. After their

unsuccessful post-award protest, Appellants separately pursued relief in various

superior courts; relying on the APA, each Appellant filed a petition seeking judicial

review of the evaluation process and moved for a stay.5 In each case, however, any

stay was lifted and the petition was dismissed after the respective superior courts

4 There is no administrative record before this Court in any case. 5 Appellant Symphony Medical, LLC, filed in the Superior Court of McIntosh County; Appellant GA Bioscience Research, Inc., filed in the Superior Court of Tift County; Appellant Pure Peach Organic, Inc., filed in the Superior Court of Dougherty County; Appellant Curaleaf GA Holdings, LLC, filed in the Superior Court of Decatur County; and Appellant ACC, LLC, filed in the Superior Court of Murray County.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Department of Human Resources v. Hutchinson
456 S.E.2d 642 (Court of Appeals of Georgia, 1995)
The BOARD OF COMMISSIONERS OF RICHMOND COUNTY v. Cooper
387 S.E.2d 138 (Supreme Court of Georgia, 1990)
Expedia, Inc. v. City of Columbus
681 S.E.2d 122 (Supreme Court of Georgia, 2009)
Scott v. State
788 S.E.2d 468 (Supreme Court of Georgia, 2016)
Deal v. Coleman
751 S.E.2d 337 (Supreme Court of Georgia, 2013)
DeKalb County School District v. Georgia State Board of Education
751 S.E.2d 827 (Supreme Court of Georgia, 2013)
Ardmare Construction Co. v. Freedman
467 A.2d 674 (Supreme Court of Connecticut, 1983)
Lott v. Hatcher
620 S.E.2d 651 (Court of Appeals of Georgia, 2005)
Welcker v. Georgia Board of Examiners of Psychologists
798 S.E.2d 368 (Court of Appeals of Georgia, 2017)
Premier Health Care Investments, LLC v. Uhs of Anchor, L.P
849 S.E.2d 441 (Supreme Court of Georgia, 2020)

Cite This Page — Counsel Stack

Bluebook (online)
SYMPHONY MEDICAL, LLC v. FFD GA HOLDINGS, LLC, Counsel Stack Legal Research, https://law.counselstack.com/opinion/symphony-medical-llc-v-ffd-ga-holdings-llc-gactapp-2023.